• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Merrimack Pharmaceuticals Inc

+ Add to Watchlist

MACK:US

10.9100 USD 0.3600 3.41%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Merrimack Pharmaceuticals Inc (MACK)

Open: 10.6100 Day's Range: 10.4600 - 11.0700 Volume: 957,845
Previous Close: 10.5500 52wk Range: 4.1300 - 11.0700 1-Yr Rtn: +110.21%

Stock Chart for MACK

No chart data available.
  • MACK:US 10.9100
  • 1D
  • 1M
  • 1Y
10.5500
Interactive MACK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MACK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.0400
Est. EPS (USD) (12/2014) -0.8830
Est. PEG Ratio -
Market Cap (M USD) 1,155.20
Shares Outstanding (M) 105.88
30 Day Average Volume 2,024,455
Price/Book (mrq) -
Price/Sale (ttm) 14.7821
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MACK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MACK

Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs for the treatment of immunological and autoimmune diseases.

Robert J MulroyPresident/CEOWilliam A SullivanCFO/Treasurer
Ulrik B NielsenSenior VP/Chief ScientificEdward J StewartSenior VP/Pres:Healthcare
More Company Profile & Key Executives for MACK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil